Week 8: Multiple Myeloma CommunityOpinion - Engage in the discussion

	MULTIPLE MYELOMA: Featured Clinical Expert:

	Sagar Lonial, MD Emory University Atlanta, Georgia, United States

Missed a Recent Conversation?

Dr. Lonial has responded to previous comments and questions. Click the link below to review.

WEEK 1: Strategies for Overcoming Adverse Risk Factors in the High Risk "Young" Patient

WEEK 2: Maintenance Therapy for Multiple Myeloma

WEEK 3: Maintenance Therapy for Multiple Myeloma, part 2

WEEK 4: Maintenance Therapy for Multiple Myeloma, part 3

WEEK 5: Autologous Stem Cell Transplantation for Multiple Myeloma

WEEK 6: Multiple Myeloma: Therapy for the Non-transplantation-eligible Patient

WEEK 7: Multiple Myeloma: Selecting Therapy Following Relapse

WEEK 8: Multiple Myeloma: Selecting Therapy in the Salvage Setting

WEEK 9: Multiple Myeloma: Transplantation

Join the Current Conversation

WEEK 10: Multiple Myeloma: Transplantation, part 2

RELATED ACTIVITY

Cases in Multiple Myeloma

This CME-certified series of 5 case studies features expert perspectives from internationally renowned thought leaders in Multiple Myeloma. Choose your preferred therapy and see the aggregate, real-time results of your peers’ choices.

Case 4: Relapsed Multiple Myeloma

	Selecting Therapy in the Salvage Setting
		Does FISH/cytogenetics, or ISS stage influence your choice of agent in the salvage setting? If so, how?

This activity is supported by an educational grant from
Millennium, The Takeda Oncology Company.

About This Activity

prIME Oncology’s CommunityOpinion is a unique educational forum that engages oncologists by having clinical experts ask prIME Oncology network members their opinion on specific contemporary and controversial topics in oncology.

The CommunityOpinion forum allows participants to respond to, share, and view other members’ answers, as well as pose questions of their own.

Join the prIME Oncology network to receive the latest in live and online education opportunities.